Adagene logo

Adagene

ADAG | NASDAQ
Chart Builder DCF Calculator
$1.60
-$0.11 (-6.43%)
At close: Nov 16, 2026, 4:00 PM ET
$1.60
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-6.43%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
49.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #298/1021 (Top 29%)

Key Statistics

Market Data

Market Cap $72.47M
1D Range
1.42 1.85
52W Range
1.42 4.78

Valuation (TTM)

PE -3.40
PB 0.68
EV/EBITDA 2.26

Valuation (NTM)

Forward PE N/A
Forward PEG -0.41
Price Target $8.00
Loading financial charts...

Profile

Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineere...

Sector Healthcare
Industry Biotechnology
Employees 128
IPO Date Feb 9, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$8.00
Upside
+400.00%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.